Anti-oestrogens as therapy for breast cancer may also reduce the risk of death from lung cancer, according to study results presented at the CTRC-AACR San Antonio Breast Cancer Symposium.

“We found a reduction in lung cancer mortality among women treated with anti-oestrogens for breast cancer. This work builds on previous studies that had suggested oestrogens have a role in lung cancer development and progression,” said Elisabetta Rapiti, MD, MPH, medical researcher with the Geneva Cancer Registry, University of Geneva, Switzerland.